Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Nature Retrieve available abstracts of 73 articles: HTML format

Single Articles

July 2024
1. GILBERT MAG, Fatima N, Jenkins J, O'Sullivan TJ, et al
   CryoET of beta-amyloid and tau within postmortem Alzheimer's disease brain.
   Nature. 2024 Jul 10. doi: 10.1038/s41586-024-07680.
   PubMed     Abstract available
   
   
   
2. SCHERES SHW
   Alzheimer's plaques and tangles revealed by 3D microscopy.
   Nature. 2024 Jul 10. doi: 10.1038/d41586-024-02119.
   PubMed    
   
   
   
3. 
   AI tool can pinpoint dementia's cause - from stroke to Alzheimer's.
   Nature. 2024 Jul 4. doi: 10.1038/d41586-024-02202.
   PubMed    
   
   
   June 2024
4. REARDON S
   Alzheimer's drug with modest benefits wins backing of FDA advisers.
   Nature. 2024 Jun 10. doi: 10.1038/d41586-024-01726.
   PubMed    
   
   
   
5. GRAHAM F
   Daily briefing: Landmark Alzheimer's paper will be retracted.
   Nature. 2024 Jun 5. doi: 10.1038/d41586-024-01699.
   PubMed    
   
   
   April 2024
6. 
   A test for Alzheimer's-disease stage predicts dementia risk.
   Nature. 2024;628:11.
   PubMed    
   
   
   
7. WEN X, Luo Z, Zhao W, Calandrelli R, et al
   Single-cell multiplex chromatin and RNA interactions in ageing human brain.
   Nature. 2024;628:648-656.
   PubMed     Abstract available
   
   
   March 2024
8. HANEY MS, Palovics R, Munson CN, Long C, et al
   APOE4/4 is linked to damaging lipid droplets in Alzheimer's disease microglia.
   Nature. 2024 Mar 13. doi: 10.1038/s41586-024-07185.
   PubMed     Abstract available
   
   
   
9. MURDOCK MH, Yang CY, Sun N, Pao PC, et al
   Multisensory gamma stimulation promotes glymphatic clearance of amyloid.
   Nature. 2024;627:149-156.
   PubMed     Abstract available
   
   
   
10. LANDHUIS E
    Researchers call for a major rethink of how Alzheimer's treatments are evaluated.
    Nature. 2024;627:S18-S20.
    PubMed    
    
    
    February 2024
11. LENHARO M
    Obesity drugs have another superpower: taming inflammation.
    Nature. 2024;626:246.
    PubMed    
    
    
    January 2024
12. KRAMER K
    Daily briefing: New evidence supports controversial hypothesis of 'transmissible' Alzheimer's.
    Nature. 2024 Jan 30. doi: 10.1038/d41586-024-00282.
    PubMed    
    
    
    
13. GRAHAM F
    Daily briefing: Drugs such as Ozempic could help with Alzheimer's and Parkinson's.
    Nature. 2024 Jan 29. doi: 10.1038/d41586-024-00272.
    PubMed    
    
    
    
14. WONG C
    Signs of 'transmissible' Alzheimer's seen in people who received growth hormone.
    Nature. 2024 Jan 29. doi: 10.1038/d41586-024-00268.
    PubMed    
    
    
    
15. LOVESTAM S, Li D, Wagstaff JL, Kotecha A, et al
    Disease-specific tau filaments assemble via polymorphic intermediates.
    Nature. 2024;625:119-125.
    PubMed     Abstract available
    
    
    
16. IRVING-PEASE EK, Refoyo-Martinez A, Barrie W, Ingason A, et al
    The selection landscape and genetic legacy of ancient Eurasians.
    Nature. 2024;625:312-320.
    PubMed     Abstract available
    
    
    December 2023
17. THOMPSON T
    How CRISPR gene editing could help treat Alzheimer's.
    Nature. 2023 Dec 11. doi: 10.1038/d41586-023-03931.
    PubMed    
    
    
    
18. OH HS, Rutledge J, Nachun D, Palovics R, et al
    Organ aging signatures in the plasma proteome track health and disease.
    Nature. 2023;624:164-172.
    PubMed     Abstract available
    
    
    November 2023
19. KOZLOV M
    AI that reads brain scans shows promise for finding Alzheimer's genes.
    Nature. 2023 Nov 10. doi: 10.1038/d41586-023-03482.
    PubMed    
    
    
    October 2023
20. REARDON S
    The brain cells linked to protection against dementia.
    Nature. 2023;622:229-230.
    PubMed    
    
    
    September 2023
21. KRAMER K
    Daily briefing: Alzheimer's makes brain cells undergo 'cellular suicide'.
    Nature. 2023 Sep 19. doi: 10.1038/d41586-023-02965.
    PubMed    
    
    
    August 2023
22. REARDON S
    Alzheimer's drug trials plagued by lack of racial diversity.
    Nature. 2023 Aug 2. doi: 10.1038/d41586-023-02464.
    PubMed    
    
    
    July 2023
23. GRAHAM F
    Daily briefing: Abnormal protein levels could be an early hallmark of Alzheimer's disease.
    Nature. 2023 Jul 24. doi: 10.1038/d41586-023-02418.
    PubMed    
    
    
    
24. REARDON S
    Alzheimer's drug donanemab helps most when taken at earliest disease stage, study finds.
    Nature. 2023 Jul 17. doi: 10.1038/d41586-023-02321.
    PubMed    
    
    
    May 2023
25. DEPP C, Sun T, Sasmita AO, Spieth L, et al
    Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer's disease.
    Nature. 2023 May 31. doi: 10.1038/s41586-023-06120.
    PubMed     Abstract available
    
    
    
26. REARDON S
    How one man's rare Alzheimer's mutation delayed the onset of disease.
    Nature. 2023 May 15. doi: 10.1038/d41586-023-01610.
    PubMed    
    
    
    
27. REARDON S
    Alzheimer's drug donanemab: what promising trial means for treatments.
    Nature. 2023 May 4. doi: 10.1038/d41586-023-01537.
    PubMed    
    
    
    April 2023
28. ABBOTT A, Thompson B
    Audio long read: Conquering Alzheimer's - a look at the therapies of the future.
    Nature. 2023 Apr 28. doi: 10.1038/d41586-023-01351.
    PubMed    
    
    
    
29. ABBOTT A
    Conquering Alzheimer's: a look at the therapies of the future.
    Nature. 2023;616:26-28.
    PubMed    
    
    
    March 2023
30. GULDNER IH, Wyss-Coray T
    Activated immune cells drive neurodegeneration in an Alzheimer's model.
    Nature. 2023 Mar 8. doi: 10.1038/d41586-023-00600.
    PubMed    
    
    
    
31. CHEN X, Firulyova M, Manis M, Herz J, et al
    Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
    Nature. 2023;615:668-677.
    PubMed     Abstract available
    
    
    February 2023
32. REIMAN EM
    Drug trial for Alzheimer's disease is a game changer.
    Nature. 2023 Feb 13. doi: 10.1038/d41586-023-00393.
    PubMed    
    
    
    
33. MARTIN-PENA A, Tansey MG
    The Alzheimer's risk gene APOE modulates the gut-brain axis.
    Nature. 2023 Feb 6. doi: 10.1038/d41586-023-00261.
    PubMed    
    
    
    January 2023
34. ELSE H
    Alzheimer's drug saga prompts journal to scrutinize whistle-blowers.
    Nature. 2023 Jan 12. doi: 10.1038/d41586-023-00050.
    PubMed    
    
    
    
35. REARDON S
    FDA approves Alzheimer's drug lecanemab amid safety concerns.
    Nature. 2023;613:227-228.
    PubMed    
    
    
    November 2022
36. PRILLAMAN M
    Heralded Alzheimer's drug works - but safety concerns loom.
    Nature. 2022 Nov 30. doi: 10.1038/d41586-022-04240.
    PubMed    
    
    
    
37. YUAN P, Zhang M, Tong L, Morse TM, et al
    PLD3 affects axonal spheroids and network defects in Alzheimer's disease.
    Nature. 2022 Nov 30. doi: 10.1038/s41586-022-05491.
    PubMed     Abstract available
    
    
    
38. COBOS I, Palop JJ
    Swollen axons impair neuronal circuits in Alzheimer's disease.
    Nature. 2022 Nov 30. doi: 10.1038/d41586-022-03800.
    PubMed    
    
    
    
39. GRAHAM F
    Daily briefing: How an Alzheimer's gene ravages the brain.
    Nature. 2022 Nov 17. doi: 10.1038/d41586-022-03780.
    PubMed    
    
    
    
40. WAGNER J, Degenhardt K, Veit M, Louros N, et al
    Medin co-aggregates with vascular amyloid-beta in Alzheimer's disease.
    Nature. 2022 Nov 16. pii: 10.1038/s41586-022-05440.
    PubMed     Abstract available
    
    
    
41. DOLGIN E
    This is how an Alzheimer's gene ravages the brain.
    Nature. 2022 Nov 16. pii: 10.1038/d41586-022-03724.
    PubMed    
    
    
    
42. PETRIC HOWE N, Thompson B
    How a key Alzheimer's gene wreaks havoc in the brain.
    Nature. 2022 Nov 16. pii: 10.1038/d41586-022-03746.
    PubMed    
    
    
    
43. CARLSTROM K, Castelo-Branco G
    Alzheimer's risk variant APOE4 linked to myelin-assembly malfunction.
    Nature. 2022 Nov 16. pii: 10.1038/d41586-022-03371.
    PubMed    
    
    
    
44. BLANCHARD JW, Akay LA, Davila-Velderrain J, von Maydell D, et al
    APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes.
    Nature. 2022;611:769-779.
    PubMed     Abstract available
    
    
    
45. DRIEU A, Du S, Storck SE, Rustenhoven J, et al
    Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid.
    Nature. 2022;611:585-593.
    PubMed     Abstract available
    
    
    October 2022
46. YANG Y, Shi Y, Schweighauser M, Zhang X, et al
    Structures of alpha-synuclein filaments from human brains with Lewy pathology.
    Nature. 2022;610:791-795.
    PubMed     Abstract available
    
    
    September 2022
47. PRILLAMAN M
    Alzheimer's drug slows mental decline in trial - but is it a breakthrough?
    Nature. 2022 Sep 29. pii: 10.1038/d41586-022-03081.
    PubMed    
    
    
    July 2022
48. NAIK S, Fuchs E
    Inflammatory memory and tissue adaptation in sickness and in health.
    Nature. 2022;607:249-255.
    PubMed     Abstract available
    
    
    
49. ZHOU Y, Su Y, Li S, Kennedy BC, et al
    Molecular landscapes of human hippocampal immature neurons across lifespan.
    Nature. 2022;607:527-533.
    PubMed     Abstract available
    
    
    June 2022
50. KARLAWISH J
    Fix the process that led to Alzheimer's drug fiasco.
    Nature. 2022;606:9.
    PubMed    
    
    
    May 2022
51. KOZLOV M
    Will the FDA change how it vets drugs following the Alzheimer's debacle?
    Nature. 2022 May 13. pii: 10.1038/d41586-022-01316.
    PubMed    
    
    
    April 2022
52. MILLER MB, Huang AY, Kim J, Zhou Z, et al
    Somatic genomic changes in single Alzheimer's disease neurons.
    Nature. 2022 Apr 20. pii: 10.1038/s41586-022-04640.
    PubMed     Abstract available
    
    
    March 2022
53. STEWART L
    The coin toss of Alzheimer's inheritance.
    Nature. 2022 Mar 17. pii: 10.1038/d41586-022-00659.
    PubMed    
    
    
    
54. XIONG J, Kang SS, Wang Z, Liu X, et al
    FSH blockade improves cognition in mice with Alzheimer's disease.
    Nature. 2022 Mar 2. pii: 10.1038/s41586-022-04463.
    PubMed     Abstract available
    
    
    
55. 
    A pituitary hormone has a key role in Alzheimer's disease.
    Nature. 2022 Mar 2. pii: 10.1038/d41586-022-00530.
    PubMed    
    
    
    
56. ABBOTT A
    Could drugs prevent Alzheimer's? These trials aim to find out.
    Nature. 2022;603:216-219.
    PubMed    
    
    
    February 2022
57. YANG AC, Vest RT, Kern F, Lee DP, et al
    A human brain vascular atlas reveals diverse mediators of Alzheimer's risk.
    Nature. 2022 Feb 14. pii: 10.1038/s41586-021-04369.
    PubMed     Abstract available
    
    
    
58. 
    Molecular map of the human blood-brain barrier reveals links to Alzheimer's disease.
    Nature. 2022 Feb 14. pii: 10.1038/d41586-022-00350.
    PubMed    
    
    
    December 2021
59. DE MIGUEL Z, Khoury N, Betley MJ, Lehallier B, et al
    Exercise plasma boosts memory and dampens brain inflammation via clusterin.
    Nature. 2021;600:494-499.
    PubMed     Abstract available
    
    
    November 2021
60. ROBINSON A
    Defining Alzheimer's, and the climate costs of AI: Books in brief.
    Nature. 2021 Nov 19. pii: 10.1038/d41586-021-03484.
    PubMed    
    
    
    
61. MULLARD A
    More Alzheimer's drugs head for FDA review: what scientists are watching.
    Nature. 2021 Nov 15. pii: 10.1038/d41586-021-03410.
    PubMed    
    
    
    October 2021
62. STAHLBERG H, Riek R
    Structural strains of misfolded tau protein define different diseases.
    Nature. 2021;598:264-265.
    PubMed    
    
    
    
63. BERG J, Sorensen SA, Ting JT, Miller JA, et al
    Human neocortical expansion involves glutamatergic neuron diversification.
    Nature. 2021;598:151-158.
    PubMed     Abstract available
    
    
    July 2021
64. BARRON JJ, Molofsky AV
    A protective signal between the brain's supporting cells in Alzheimer's disease.
    Nature. 2021 Jul 14. pii: 10.1038/d41586-021-01870.
    PubMed    
    
    
    
65. MCALPINE CS, Park J, Griciuc A, Kim E, et al
    Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease.
    Nature. 2021 Jul 14. pii: 10.1038/s41586-021-03734.
    PubMed     Abstract available
    
    
    June 2021
66. MULLARD A
    Controversial Alzheimer's drug approval could affect other diseases.
    Nature. 2021 Jun 29. pii: 10.1038/d41586-021-01763.
    PubMed    
    
    
    
67. GRAHAM F
    Daily briefing: Alzheimer's drug controversially approved by FDA.
    Nature. 2021 Jun 8. pii: 10.1038/d41586-021-01553.
    PubMed    
    
    
    
68. MULLARD A
    Landmark Alzheimer's drug approval confounds research community.
    Nature. 2021 Jun 8. pii: 10.1038/d41586-021-01546.
    PubMed    
    
    
    May 2021
69. ABASCAL F, Harvey LMR, Mitchell E, Lawson ARJ, et al
    Somatic mutation landscapes at single-molecule resolution.
    Nature. 2021;593:405-410.
    PubMed     Abstract available
    
    
    
70. DA MESQUITA S, Papadopoulos Z, Dykstra T, Brase L, et al
    Meningeal lymphatics affect microglia responses and anti-Abeta immunotherapy.
    Nature. 2021;593:255-260.
    PubMed     Abstract available
    
    
    February 2021
71. WILLYARD C
    How gut microbes could drive brain disorders.
    Nature. 2021;590:22-25.
    PubMed    
    
    
    January 2021
72. ELSE H
    The science events to watch for in 2021.
    Nature. 2021;589:14-15.
    PubMed    
    
    
    November 2020
73. ABBOTT A
    Are infections seeding some cases of Alzheimer's disease?
    Nature. 2020;587:22-25.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.